7,417 Shares in The Cooper Companies, Inc. $COO Purchased by Bull Harbor Capital LLC

Bull Harbor Capital LLC acquired a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) in the first quarter, according to the company in its most recent filing with the SEC. The firm acquired 7,417 shares of the medical device company’s stock, valued at approximately $530,000.

Other hedge funds have also added to or reduced their stakes in the company. State Street Corp increased its position in shares of Cooper Companies by 2.4% during the fourth quarter. State Street Corp now owns 8,793,747 shares of the medical device company’s stock worth $720,736,000 after acquiring an additional 207,195 shares during the period. Wellington Management Group LLP boosted its holdings in shares of Cooper Companies by 332.9% in the third quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock valued at $424,043,000 after purchasing an additional 4,756,178 shares during the period. Price T Rowe Associates Inc. MD boosted its holdings in shares of Cooper Companies by 58.8% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 6,028,821 shares of the medical device company’s stock valued at $494,123,000 after purchasing an additional 2,231,568 shares during the period. Sustainable Growth Advisers LP grew its stake in Cooper Companies by 22.1% in the third quarter. Sustainable Growth Advisers LP now owns 4,132,535 shares of the medical device company’s stock worth $283,327,000 after purchasing an additional 747,476 shares in the last quarter. Finally, Franklin Resources Inc. grew its stake in Cooper Companies by 108.2% in the fourth quarter. Franklin Resources Inc. now owns 4,022,033 shares of the medical device company’s stock worth $329,646,000 after purchasing an additional 2,089,763 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research firms have commented on COO. Weiss Ratings downgraded Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a report on Monday, June 8th. JPMorgan Chase & Co. lowered their target price on Cooper Companies from $80.00 to $71.00 and set a “neutral” rating for the company in a report on Friday, June 5th. Needham & Company LLC dropped their price target on Cooper Companies from $101.00 to $86.00 and set a “buy” rating on the stock in a research report on Friday, June 5th. Mizuho set a $85.00 price target on Cooper Companies and gave the company an “outperform” rating in a research note on Thursday, June 4th. Finally, Piper Sandler set a $86.00 price objective on Cooper Companies and gave the company an “overweight” rating in a report on Monday, June 1st. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, six have given a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $81.36.

Cooper Companies Stock Down 0.5%

Cooper Companies stock opened at $72.32 on Friday. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23. The firm has a market cap of $14.10 billion, a P/E ratio of 61.29, a P/E/G ratio of 1.90 and a beta of 0.84. The business has a fifty day moving average of $68.36 and a two-hundred day moving average of $71.79. The Cooper Companies, Inc. has a twelve month low of $58.89 and a twelve month high of $89.83.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. The business had revenue of $1.08 billion for the quarter, compared to the consensus estimate of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The business’s revenue was up 7.9% compared to the same quarter last year. During the same period last year, the business posted $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, analysts forecast that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.